Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Birk Poller

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Journal of Pharmaceutical Sciences|April 8, 2017
Current In Vitro Methods to Determine Hepatic Kp<sub>uu</sub>: A Comparison of Their Usefulness and LimitationsJulia Riede, Gian Camenisch, Jörg Huwyler, et al.
Drug Metabolism and Personalized Therapy|May 22, 2015
Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statinsAnnett Kunze, Birk Poller, Jörg Huwyler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2017
Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic ConcentrationsJulia Riede, Birk Poller, Jörg Huwyler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2014
Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity dataAnnett Kunze, Jörg Huwyler, Gian Camenisch, et al.
Cellular and Molecular Neurobiology|July 25, 2009
Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrierBirk Poller, Jürgen Drewe, Stephan Krähenbühl, et al.
Molecular Pharmaceutics|February 12, 2011
Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrierBirk Poller, Els Wagenaar, Seng Chuan Tang, et al.
Journal of Pharmaceutical Sciences|February 20, 2014
In vitro-in vivo extrapolation method to predict human renal clearance of drugsAnnett Kunze, Jörg Huwyler, Birk Poller, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2016
New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome dataJulia Riede, Birk Poller, Ken-ichi Umehara, et al.
Pharmaceutical Research|March 2, 2023
Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug DiscoveryMitesh Patel, Julia Riede, Dallas Bednarczyk, et al.
The American Journal of Clinical Nutrition|August 20, 2010
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjectsRobert E Steinert, Birk Poller, M Cristina Castelli, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Journal of Pharmaceutical Sciences|April 8, 2017
Current In Vitro Methods to Determine Hepatic Kp<sub>uu</sub>: A Comparison of Their Usefulness and LimitationsJulia Riede, Gian Camenisch, Jörg Huwyler, et al.
Drug Metabolism and Personalized Therapy|May 22, 2015
Application of the extended clearance concept classification system (ECCCS) to predict the victim drug-drug interaction potential of statinsAnnett Kunze, Birk Poller, Jörg Huwyler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 4, 2017
Assessing the Risk of Drug-Induced Cholestasis Using Unbound Intrahepatic ConcentrationsJulia Riede, Birk Poller, Jörg Huwyler, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|July 4, 2014
Prediction of organic anion-transporting polypeptide 1B1- and 1B3-mediated hepatic uptake of statins based on transporter protein expression and activity dataAnnett Kunze, Jörg Huwyler, Gian Camenisch, et al.
Cellular and Molecular Neurobiology|July 25, 2009
Regulation of BCRP (ABCG2) and P-glycoprotein (ABCB1) by cytokines in a model of the human blood-brain barrierBirk Poller, Jürgen Drewe, Stephan Krähenbühl, et al.
Molecular Pharmaceutics|February 12, 2011
Double-transduced MDCKII cells to study human P-glycoprotein (ABCB1) and breast cancer resistance protein (ABCG2) interplay in drug transport across the blood-brain barrierBirk Poller, Els Wagenaar, Seng Chuan Tang, et al.
Journal of Pharmaceutical Sciences|February 20, 2014
In vitro-in vivo extrapolation method to predict human renal clearance of drugsAnnett Kunze, Jörg Huwyler, Birk Poller, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|March 8, 2016
New IVIVE method for the prediction of total human clearance and relative elimination pathway contributions from in vitro hepatocyte and microsome dataJulia Riede, Birk Poller, Ken-ichi Umehara, et al.
Pharmaceutical Research|March 2, 2023
Simplifying the Extended Clearance Concept Classification System (EC3S) to Guide Clearance Prediction in Drug DiscoveryMitesh Patel, Julia Riede, Dallas Bednarczyk, et al.
The American Journal of Clinical Nutrition|August 20, 2010
Oral administration of glucagon-like peptide 1 or peptide YY 3-36 affects food intake in healthy male subjectsRobert E Steinert, Birk Poller, M Cristina Castelli, et al.
Pageof 4